InvestLog
ELVN logo

ELVN

Enliven Therapeutics, Inc.NASDAQHealthcare
$38.83+2.75%ClosedMarket Cap: $2.32B

As of 2026-04-06

Recent Analyst Ratings
DateFirmActionRatingPrevious
2026-03-26HC Wainwright & Co.—Buy—
2026-03-25Mizuho—Outperform—
2025-07-02HC Wainwright & Co.—Buy—
2025-06-16Baird—Outperform—
2025-05-16Jones Trading—Buy—
2025-05-15HC Wainwright & Co.—Buy—
Forward Estimates
PeriodEPS Est.Revenue Est.# Analysts
Fri Dec 31$-2.78$16.7K2
Sun Dec 31$-3.45$25.0K5
Mon Dec 31$-3.47$80.4M1
Tue Dec 31$-1.90$316.5M1